National antidepressant‑withdrawal registry

Create a standardized, publicly governed registry that prospectively collects anonymized patient‑level data on antidepressant discontinuation: taper schedules, symptoms (onset, severity, duration), prior treatment history, clinician interventions, and outcomes. The registry would accept clinician reports, patient submissions (with verification), and platform‑aggregated signal data to enable real‑time surveillance, robust epidemiology, and rapid guideline updates. — A national registry would convert anecdote and scattered case series into auditable evidence that can drive safer prescribing, informed‑consent norms, insurance coverage for taper supports, and regulatory decisions about labeling and monitoring.